Scientific and regulatory considerations on the immunogenicity of biologics

Trends in Biotechnology
Gopi ShankarA R Mire-Sluis

Abstract

Immune responses against non-vaccine biologics can affect their efficacy and safety, resulting in adverse events that could include administration reactions, hypersensitivity, deficiency syndromes and lack of a clinical response in treated patients. With the relatively recent development of numerous biologics, immunogenicity testing has become a key component in the demonstration of clinical safety and efficacy; in fact, it is highly unlikely that regulatory approval would be granted for a biologic without an assessment of its immunogenicity. However, recommendations from regulatory agencies regarding the requirements for when and how to carry out immunogenicity testing are dispersed among numerous guidance documents. To enable the evaluation of the effects of immunogenicity on safety and efficacy, the authors have consolidated recommendations from the regulatory guidelines, and present current approaches and future directions for the assessment of immunogenicity.

References

Feb 1, 1991·Fundamental and Applied Toxicology : Official Journal of the Society of Toxicology·C M ZwicklD Wierda
Feb 13, 2001·Toxicology·D WierdaC M Zwickl
Feb 15, 2002·The New England Journal of Medicine·Nicole CasadevallPatrick Mayeux
Jul 18, 2002·Nature Reviews. Drug Discovery·Huub Schellekens
Dec 5, 2002·Current Pharmaceutical Biotechnology·E KorenA R Mire-Sluis
Nov 12, 2003·Neurology·Huub Schellekens
Jan 30, 2004·Journal of the American Society of Nephrology : JASN·Jerome RossertKai-Uwe Eckardt
Jun 21, 2005·Journal of Pharmaceutical and Biomedical Analysis·Dong GengCarrie Wagner

❮ Previous
Next ❯

Citations

Sep 6, 2012·Bioanalysis·Lukas BütikoferHeinrich Faust
Jul 24, 2012·Therapeutic Delivery·Saileta PrabhuBert L Lum
May 7, 2013·Bioanalysis·Montserrat Carrasco-TrigueroSurinder Kaur
May 7, 2013·Bioanalysis·Sarah A HoofringMarta Starcevic
Jan 12, 2013·Journal of Immunological Methods·Lanju ZhangHarry Yang
May 28, 2014·Journal of Immunological Methods·Boris GorovitsJaya Goyal
May 13, 2014·Rheumatology International·Francisca Llinares-TelloUNKNOWN AIRE-MB Group
Mar 4, 2009·The AAPS Journal·Boris Gorovits
Aug 19, 2009·Antimicrobial Agents and Chemotherapy·Karoline Sidelmann BrinchHans-Henrik Kristensen
Sep 13, 2011·Protein Engineering, Design & Selection : PEDS·Margaret E AckermanK Dane Wittrup
Oct 15, 2011·Nature Biotechnology·Chen YanoverZuben E Sauna
Aug 8, 2013·Journal of Immunotoxicology·Kirsty D RatanjiIan Kimber
Sep 24, 2015·Expert Review of Clinical Immunology·Ji Soo KimSeungSuh Hong
Mar 1, 2008·Expert Opinion on Drug Discovery·Andreas Baumann
Nov 1, 2010·Expert Opinion on Drug Discovery·Andreas Nechansky, Ralf Kircheis
Jun 26, 2015·Journal of Pharmaceutical Sciences·Sahar AwwadPeng T Khaw
Dec 17, 2015·The Journal of Pharmacology and Experimental Therapeutics·Nicholas D BrunnEnrique Escandon
Dec 19, 2012·Journal of Pharmaceutical and Biomedical Analysis·Robert J KubiakLorin K Roskos
May 2, 2012·International Journal of Pharmaceutics·Wei WangSandeep Nema
Feb 23, 2011·Regulatory Toxicology and Pharmacology : RTP·Baolai ZhangYongjie Wu
Jan 23, 2009·Health Policy·Hiroshi HorikawaKoji Kawakami
Jul 16, 2008·Current Opinion in Immunology·Lucien AardenGertjan Wolbink
May 1, 2007·Biomolecular Engineering·David Filpula
Jan 25, 2007·Basic & Clinical Pharmacology & Toxicology·Michael J ParnhamMarija Kozlović
Feb 9, 2010·Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·Kathrin SchererAndreas J Bircher
Jul 7, 2009·Biochemical and Biophysical Research Communications·Mark SpenglerChristof M Niemeyer
Feb 29, 2008·Journal of Immunological Methods·Denise SickertAnnette Zaar
May 20, 2015·Best Practice & Research. Clinical Endocrinology & Metabolism·Brian W BiggerGabor E Linthorst

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bioinformatics in Biomedicine

Bioinformatics in biomedicine incorporates computer science, biology, chemistry, medicine, mathematics and statistics. Discover the latest research on bioinformatics in biomedicine here.

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.